Modulation of HIV-1 Gag NC/p1 cleavage efficiency affects protease inhibitor resistance and viral replicative capacity.

Abstract:

BACKGROUND:Mutations in the substrate of HIV-1 protease, especially changes in the NC/p1 cleavage site, can directly contribute to protease inhibitor (PI) resistance and also compensate for defects in viral replicative capacity (RC) due to a drug resistant protease. These NC/p1 changes are known to enhance processing of the Gag protein. To investigate the capacity of HIV-1 to modulate Gag cleavage and its consequences for PI resistance and RC, we performed a detailed enzymatic and virological analysis using a set of PI resistant NC/p1 variants (HXB2431V, HXB2436E+437T, HXB2437T and HXB2437V). RESULTS:Here, we demonstrate that single NC/p1 mutants, which displayed only a slight increase in PI resistance did not show an obvious change in RC. In contrast, the double NC/p1 mutant, which displayed a clear increase in processing efficiency and PI resistance, demonstrated a clear reduction in RC. Cleavage analysis showed that a tridecameric NC/p1 peptide representing the double NC/p1 mutant was cleaved in two specific ways instead of one.The observed decrease in RC for the double NC/p1 mutant (HXB2436E+437T) could (partially) be restored by either reversion of the 436E change or by acquisition of additional changes in the NC/p1 cleavage site at codon 435 or 438 as was revealed during in vitro evolution experiments. These changes not only restored RC but also reduced PI resistance levels. Furthermore these changes normalized Gag processing efficiency and obstructed the novel secondary cleavage site observed for the double NC/p1 mutant. CONCLUSIONS:The results of this study clearly demonstrate that HIV-1 can modulate Gag processing and thereby PI resistance. Distinct increases in Gag cleavage and PI resistance result in a reduced RC that can only be restored by amino acid changes in NC/p1 which reduce Gag processing to an optimal rate.

journal_name

Retrovirology

journal_title

Retrovirology

authors

van Maarseveen NM,Andersson D,Lepšík M,Fun A,Schipper PJ,de Jong D,Boucher CA,Nijhuis M

doi

10.1186/1742-4690-9-29

subject

Has Abstract

pub_date

2012-04-01 00:00:00

pages

29

issn

1742-4690

pii

1742-4690-9-29

journal_volume

9

pub_type

杂志文章
  • Small non-coding RNAs, mammalian cells, and viruses: regulatory interactions?

    abstract::Recent findings suggest that mammalian cells can use small non-coding RNAs (ncRNA) to regulate physiological viral infections. Here, we comment on several lines of evidence that support this concept. We discuss how viruses may in turn protect, suppress, evade, modulate, or adapt to the host cell's ncRNA regulatory sch...

    journal_title:Retrovirology

    pub_type: 社论,评审

    doi:10.1186/1742-4690-4-74

    authors: Yeung ML,Benkirane M,Jeang KT

    更新日期:2007-10-15 00:00:00

  • Stabilization of the β-hairpin in Mason-Pfizer monkey virus capsid protein- a critical step for infectivity.

    abstract:BACKGROUND:Formation of a mature core is a crucial event for infectivity of retroviruses such as Mason-Pfizer monkey virus (M-PMV). The process is triggered by proteolytic cleavage of the polyprotein precursor Gag, which releases matrix, capsid (CA), and nucleocapsid proteins. Once released, CA assembles to form a matu...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/s12977-014-0094-8

    authors: Obr M,Hadravová R,DoleŽal M,KříŽová I,Papoušková V,Zídek L,Hrabal R,Ruml T,Rumlová M

    更新日期:2014-10-30 00:00:00

  • Proteasome inhibitors act as bifunctional antagonists of human immunodeficiency virus type 1 latency and replication.

    abstract:BACKGROUND:Existing highly active antiretroviral therapy (HAART) effectively controls viral replication in human immunodeficiency virus type 1 (HIV-1) infected individuals but cannot completely eradicate the infection, at least in part due to the persistence of latently infected cells. One strategy that is being active...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/1742-4690-10-120

    authors: Miller LK,Kobayashi Y,Chen CC,Russnak TA,Ron Y,Dougherty JP

    更新日期:2013-10-24 00:00:00

  • Evolution and gene capture in ancient endogenous retroviruses - insights from the crocodilian genomes.

    abstract:BACKGROUND:Crocodilians are thought to be hosts to a diverse and divergent complement of endogenous retroviruses (ERVs) but a comprehensive investigation is yet to be performed. The recent sequencing of three crocodilian genomes provides an opportunity for a more detailed and accurate representation of the ERV diversit...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/s12977-014-0071-2

    authors: Chong AY,Kojima KK,Jurka J,Ray DA,Smit AF,Isberg SR,Gongora J

    更新日期:2014-12-12 00:00:00

  • Modulation of the virus-receptor interaction by mutations in the V5 loop of feline immunodeficiency virus (FIV) following in vivo escape from neutralising antibody.

    abstract:BACKGROUND:In the acute phase of infection with feline immunodeficiency virus (FIV), the virus targets activated CD4+ T cells by utilising CD134 (OX40) as a primary attachment receptor and CXCR4 as a co-receptor. The nature of the virus-receptor interaction varies between isolates; strains such as GL8 and CPGammer reco...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/1742-4690-7-38

    authors: Willett BJ,Kraase M,Logan N,McMonagle EL,Samman A,Hosie MJ

    更新日期:2010-04-26 00:00:00

  • PCR mediated recombination impacts the analysis of hepatitis B Virus covalently closed circular DNA.

    abstract:BACKGROUND:The replication of HBV involves the production of covalently closed circular DNA (cccDNA) from the HBV genome through the repair of virion relaxed circular DNA (rcDNA) in the virion. As cccDNA is the transcription template for HBV genomes, it needs to be eliminated from hepatocytes if the eradication of chro...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/s12977-016-0318-1

    authors: Suspène R,Thiers V,Vartanian JP,Wain-Hobson S

    更新日期:2016-12-20 00:00:00

  • Higher levels of Zidovudine resistant HIV in the colon compared to blood and other gastrointestinal compartments in HIV infection.

    abstract:BACKGROUND:The gut-associated lymphoid tissue (GALT) is the largest lymphoid organ infected by human immunodeficiency virus type 1 (HIV-1). It serves as a viral reservoir and host-pathogen interface in infection. This study examined whether different parts of the gut and peripheral blood lymphocytes (PBL) contain diffe...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/1742-4690-7-74

    authors: van Marle G,Church DL,Nunweiler KD,Cannon K,Wainberg MA,Gill MJ

    更新日期:2010-09-13 00:00:00

  • A comparison of the ability of rilpivirine (TMC278) and selected analogues to inhibit clinically relevant HIV-1 reverse transcriptase mutants.

    abstract:BACKGROUND:The recently approved anti-AIDS drug rilpivirine (TMC278, Edurant) is a nonnucleoside inhibitor (NNRTI) that binds to reverse transcriptase (RT) and allosterically blocks the chemical step of DNA synthesis. In contrast to earlier NNRTIs, rilpivirine retains potency against well-characterized, clinically rele...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/1742-4690-9-99

    authors: Johnson BC,Pauly GT,Rai G,Patel D,Bauman JD,Baker HL,Das K,Schneider JP,Maloney DJ,Arnold E,Thomas CJ,Hughes SH

    更新日期:2012-12-05 00:00:00

  • HLA-B*35 as a new marker for susceptibility to human T-cell lymphotropic virus type 1 (HTLV-1) Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) in patients living in Argentina.

    abstract:BACKGROUND:Human T-cell lymphotropic virus type 1 (HTLV-1) is the etiological agent of HTLV associated myelopathy/ Tropical Spastic Paraparesis (HAM/TSP) and Adult T cell leukemia/lymphoma (ATLL), in around 2-5% of the infected individuals. Host genetic background might play a role in disease progression. Several previ...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/s12977-020-00536-y

    authors: Benencio P,Fraile Gonzalez SA,Ducasa N,Page K,Berini CA,Biglione MM

    更新日期:2020-09-03 00:00:00

  • Identification of the feline foamy virus Bet domain essential for APOBEC3 counteraction.

    abstract:BACKGROUND:APOBEC3 (A3) proteins restrict viral replication by cytidine deamination of viral DNA genomes and impairing reverse transcription and integration. To escape this restriction, lentiviruses have evolved the viral infectivity factor (Vif), which binds A3 proteins and targets them for proteolytic degradation. In...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/1742-4690-10-76

    authors: Lukic DS,Hotz-Wagenblatt A,Lei J,Räthe AM,Mühle M,Denner J,Münk C,Löchelt M

    更新日期:2013-07-24 00:00:00

  • Analysis of herpes simplex type 1 gB, gD, and gH/gL on production of infectious HIV-1: HSV-1 gD restricts HIV-1 by exclusion of HIV-1 Env from maturing viral particles.

    abstract:BACKGROUND:We previously showed that the gM of HSV-1 could restrict the release of infectious HIV-1 from cells. In this study, we analyzed if the four HSV-1 glycoproteins (gD, gB, and gH/gL), which are the minimum glycoproteins required for HSV-1 entry, restricted the release of infectious HIV-1. RESULTS:Of these four...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/s12977-019-0470-5

    authors: Polpitiya Arachchige S,Henke W,Kalamvoki M,Stephens EB

    更新日期:2019-04-02 00:00:00

  • TNPO3 protects HIV-1 replication from CPSF6-mediated capsid stabilization in the host cell cytoplasm.

    abstract:BACKGROUND:Despite intensive investigation the mechanism by which HIV-1 reaches the host cell nucleus is unknown. TNPO3, a karyopherin mediating nuclear entry of SR-proteins, was shown to be required for HIV-1 infectivity. Some investigators have reported that TNPO3 promotes HIV-1 nuclear import, as would be expected f...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/1742-4690-10-20

    authors: De Iaco A,Santoni F,Vannier A,Guipponi M,Antonarakis S,Luban J

    更新日期:2013-02-15 00:00:00

  • Crystal structure of an FIV/HIV chimeric protease complexed with the broad-based inhibitor, TL-3.

    abstract::We have obtained the 1.7 A crystal structure of FIV protease (PR) in which 12 critical residues around the active site have been substituted with the structurally equivalent residues of HIV PR (12X FIV PR). The chimeric PR was crystallized in complex with the broad-based inhibitor TL-3, which inhibits wild type FIV an...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/1742-4690-4-1

    authors: Heaslet H,Lin YC,Tam K,Torbett BE,Elder JH,Stout CD

    更新日期:2007-01-09 00:00:00

  • The role of integration and clonal expansion in HIV infection: live long and prosper.

    abstract::Integration of viral DNA into the host genome is a central event in the replication cycle and the pathogenesis of retroviruses, including HIV. Although most cells infected with HIV are rapidly eliminated in vivo, HIV also infects long-lived cells that persist during combination antiretroviral therapy (cART). Cells wit...

    journal_title:Retrovirology

    pub_type: 杂志文章,评审

    doi:10.1186/s12977-018-0448-8

    authors: Anderson EM,Maldarelli F

    更新日期:2018-10-23 00:00:00

  • Tenofovir treatment augments anti-viral immunity against drug-resistant SIV challenge in chronically infected rhesus macaques.

    abstract:BACKGROUND:Emergence of drug-resistant strains of human immunodeficiency virus type 1 (HIV-1) is a major obstacle to successful antiretroviral therapy (ART) in HIV-infected patients. Whether antiviral immunity can augment ART by suppressing replication of drug-resistant HIV-1 in humans is not well understood, but can b...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/1742-4690-3-97

    authors: Metzner KJ,Binley JM,Gettie A,Marx P,Nixon DF,Connor RI

    更新日期:2006-12-21 00:00:00

  • Targeted infection of HIV-1 Env expressing cells by HIV(CD4/CXCR4) vectors reveals a potential new rationale for HIV-1 mediated down-modulation of CD4.

    abstract:BACKGROUND:Efficient targeted gene transfer and cell type specific transgene expression are important for the safe and effective expression of transgenes in vivo. Enveloped viral vectors allow insertion of exogenous membrane proteins into their envelopes, which could potentially aid in the targeted transduction of spec...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/1742-4690-2-80

    authors: Ye Z,Harmison GG,Ragheb JA,Schubert M

    更新日期:2005-12-21 00:00:00

  • Limited cross-border infections in patients newly diagnosed with HIV in Europe.

    abstract:BACKGROUND:International travel plays a role in the spread of HIV-1 across Europe. It is, however, not known whether international travel is more important for spread of the epidemic as compared to endogenous infections within single countries. In this study, phylogenetic associations among HIV of newly diagnosed patie...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/1742-4690-10-36

    authors: Frentz D,Wensing AM,Albert J,Paraskevis D,Abecasis AB,Hamouda O,Jørgensen LB,Kücherer C,Struck D,Schmit JC,Åsjö B,Balotta C,Beshkov D,Camacho RJ,Clotet B,Coughlan S,De Wit S,Griskevicius A,Grossman Z,Horban A,Kolu

    更新日期:2013-04-03 00:00:00

  • Kinetic variations between reverse transcriptases of viral protein X coding and noncoding lentiviruses.

    abstract:BACKGROUND:Host SAM domain and HD domain-containing protein 1 (SAMHD1) suppresses reverse transcription kinetics of HIV-1 in nondividing cells such as macrophages by hydrolyzing and nearly depleting cellular dNTPs, which are the substrates of viral reverse transcriptase (RT). However, unlike HIV-1, HIV-2 and SIVsm enco...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/s12977-014-0111-y

    authors: Lenzi GM,Domaoal RA,Kim DH,Schinazi RF,Kim B

    更新日期:2014-12-19 00:00:00

  • Tat RNA silencing suppressor activity contributes to perturbation of lymphocyte miRNA by HIV-1.

    abstract:BACKGROUND:MicroRNA (miRNA)-mediated RNA silencing is integral to virtually every cellular process including cell cycle progression and response to virus infection. The interplay between RNA silencing and HIV-1 is multifaceted, and accumulating evidence posits a strike-counterstrike interface that alters the cellular e...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/1742-4690-8-36

    authors: Hayes AM,Qian S,Yu L,Boris-Lawrie K

    更新日期:2011-05-13 00:00:00

  • Passive immunization of macaques with polyclonal anti-SHIV IgG against a heterologous tier 2 SHIV: outcome depends on IgG dose.

    abstract:BACKGROUND:A key goal for HIV-1 envelope immunogen design is the induction of cross-reactive neutralizing antibodies (nAbs). As AIDS vaccine recipients will not be exposed to strains exactly matching any immunogens due to multiple HIV-1 quasispecies circulating in the human population worldwide, heterologous SHIV chall...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/1742-4690-11-8

    authors: Sholukh AM,Byrareddy SN,Shanmuganathan V,Hemashettar G,Lakhashe SK,Rasmussen RA,Watkins JD,Vyas HK,Thorat S,Brandstoetter T,Mukhtar MM,Yoon JK,Novembre FJ,Villinger F,Landucci G,Forthal DN,Ratcliffe S,Tuero I,Robert-G

    更新日期:2014-01-20 00:00:00

  • Functional analysis of human T lymphotropic virus type 2 Tax proteins.

    abstract:BACKGROUND:The Tax proteins encoded by human T lymphotropic virus type 1 (HTLV-1) and type 2 (HTLV-2) are transcriptional activators of both the viral long terminal repeat (LTR) and cellular promoters via the CREB and NFkB pathways. In contrast to HTLV-1, HTLV-2 has been classified into four distinct genetic subtypes A...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/1742-4690-3-20

    authors: Sheehy N,Lillis L,Watters K,Lewis M,Gautier V,Hall W

    更新日期:2006-03-21 00:00:00

  • Utilization of HIV-1 envelope V3 to identify X4- and R5-specific Tat and LTR sequence signatures.

    abstract:BACKGROUND:HIV-1 entry is a receptor-mediated process directed by the interaction of the viral envelope with the host cell CD4 molecule and one of two co-receptors, CCR5 or CXCR4. The amino acid sequence of the third variable (V3) loop of the HIV-1 envelope is highly predictive of co-receptor utilization preference dur...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/s12977-016-0266-9

    authors: Antell GC,Dampier W,Aiamkitsumrit B,Nonnemacher MR,Jacobson JM,Pirrone V,Zhong W,Kercher K,Passic S,Williams JW,Schwartz G,Hershberg U,Krebs FC,Wigdahl B

    更新日期:2016-05-03 00:00:00

  • Establishment of a novel diagnostic test algorithm for human T-cell leukemia virus type 1 infection with line immunoassay replacement of western blotting: a collaborative study for performance evaluation of diagnostic assays in Japan.

    abstract:BACKGROUND:The reliable diagnosis of human T-cell leukemia virus type 1 (HTLV-1) infection is important, particularly as it can be vertically transmitted by breast feeding mothers to their infants. However, current diagnosis in Japan requires a confirmatory western blot (WB) test after screening/primary testing for HTL...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/s12977-020-00534-0

    authors: Okuma K,Kuramitsu M,Niwa T,Taniguchi T,Masaki Y,Ueda G,Matsumoto C,Sobata R,Sagara Y,Nakamura H,Satake M,Miura K,Fuchi N,Masuzaki H,Okayama A,Umeki K,Yamano Y,Sato T,Iwanaga M,Uchimaru K,Nakashima M,Utsunomiya A

    更新日期:2020-08-24 00:00:00

  • Modulation of HIV-1-host interaction: role of the Vpu accessory protein.

    abstract::Viral protein U (Vpu) is a type 1 membrane-associated accessory protein that is unique to human immunodeficiency virus type 1 (HIV-1) and a subset of related simian immunodeficiency virus (SIV). The Vpu protein encoded by HIV-1 is associated with two primary functions during the viral life cycle. First, it contributes...

    journal_title:Retrovirology

    pub_type: 杂志文章,评审

    doi:10.1186/1742-4690-7-114

    authors: Dubé M,Bego MG,Paquay C,Cohen ÉA

    更新日期:2010-12-22 00:00:00

  • TLR2 and TLR4 triggering exerts contrasting effects with regard to HIV-1 infection of human dendritic cells and subsequent virus transfer to CD4+ T cells.

    abstract:BACKGROUND:Recognition of microbial products through Toll-like receptors (TLRs) initiates inflammatory responses orchestrated by innate immune cells such as dendritic cells (DCs). As these cells are patrolling mucosal surfaces, a portal of entry for various pathogens including human immunodeficiency virus type-1 (HIV-1...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/1742-4690-6-42

    authors: Thibault S,Fromentin R,Tardif MR,Tremblay MJ

    更新日期:2009-05-06 00:00:00

  • The XVI International Conference on AIDS: the place to be!

    abstract::This editorial represents a plea to retrovirologists to attend the XVI International Conference on AIDS that will take place in Toronto, Canada between August 13-18, 2006. In short, it is vital that politicians and opinion leaders understand that basic scientists are no less committed to the worldwide battle against H...

    journal_title:Retrovirology

    pub_type: 社论

    doi:10.1186/1742-4690-3-9

    authors: Wainberg MA

    更新日期:2006-02-03 00:00:00

  • An expanded model of HIV cell entry phenotype based on multi-parameter single-cell data.

    abstract:BACKGROUND:Entry of human immunodeficiency virus type 1 (HIV-1) into the host cell involves interactions between the viral envelope glycoproteins (Env) and the cellular receptor CD4 as well as a coreceptor molecule (most importantly CCR5 or CXCR4). Viral preference for a specific coreceptor (tropism) is in particular d...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/1742-4690-9-60

    authors: Bozek K,Eckhardt M,Sierra S,Anders M,Kaiser R,Kräusslich HG,Müller B,Lengauer T

    更新日期:2012-07-25 00:00:00

  • Enhanced antibody-mediated neutralization of HIV-1 variants that are resistant to fusion inhibitors.

    abstract:BACKGROUND:HIV-1 typically develops resistance to any single antiretroviral agent. Combined anti-retroviral therapy to reduce drug-resistance development is necessary to control HIV-1 infection. Here, to assess the utility of a combination of antibody and fusion inhibitor treatments, we investigated the potency of mono...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/s12977-016-0304-7

    authors: Alam M,Kuwata T,Shimura K,Yokoyama M,Ramirez Valdez KP,Tanaka K,Maruta Y,Oishi S,Fujii N,Sato H,Matsuoka M,Matsushita S

    更新日期:2016-09-27 00:00:00

  • Combination of nanoparticle-based therapeutic vaccination and transient ablation of regulatory T cells enhances anti-viral immunity during chronic retroviral infection.

    abstract:BACKGROUND:Regulatory T cells (Tregs) have been shown to limit anti-viral immunity during chronic retroviral infection and to restrict vaccine-induced T cell responses. The objective of the study was to assess whether a combinational therapy of nanoparticle-based therapeutic vaccination and concomitant transient ablati...

    journal_title:Retrovirology

    pub_type: 杂志文章,评审

    doi:10.1186/s12977-016-0258-9

    authors: Knuschke T,Rotan O,Bayer W,Sokolova V,Hansen W,Sparwasser T,Dittmer U,Epple M,Buer J,Westendorf AM

    更新日期:2016-04-14 00:00:00

  • Human Immunodeficiency Virus-Type 1 LTR DNA contains an intrinsic gene producing antisense RNA and protein products.

    abstract:BACKGROUND:While viruses have long been shown to capitalize on their limited genomic size by utilizing both strands of DNA or complementary DNA/RNA intermediates to code for viral proteins, it has been assumed that human retroviruses have all their major proteins translated only from the plus or sense strand of RNA, de...

    journal_title:Retrovirology

    pub_type: 杂志文章

    doi:10.1186/1742-4690-3-80

    authors: Ludwig LB,Ambrus JL Jr,Krawczyk KA,Sharma S,Brooks S,Hsiao CB,Schwartz SA

    更新日期:2006-11-08 00:00:00